BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Panacea Biotec Ltd. Share Price

NSE
BSE

NSE : PANACEABIO

BSE : 531349

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹370.10

High

₹384.20

Price Summary

Previous Close ₹375.65
Day's Range ₹370.10 - ₹384.20
Open ₹380.70
52 Week Range ₹292.40 - ₹581.00
Volume 88,060
Market Cap ₹0.00
Previous Close ₹373.80
Day's Range ₹370.05 - ₹383.95
Open ₹381.10
52 Week Range ₹293.10 - ₹581.00
Volume 3,476
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 330.80
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 0.00
TTM EPS (₹) -1.27
P/E Ratio 0.00
Book Value(₹) 2.81
PAT Margin (%) -1.55
Face Value (₹) 1.00
ROCE(%) -0.47
Trade Value ( ₹ in Lacs) 12.99
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 0.00
TTM EPS (₹) -1.27
P/E Ratio 0.00
Book Value(₹) 2.81
PAT Margin (%) -1.55
Face Value (₹) 1.00
ROCE(%) -0.47

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 1084.3 3596.0
Expenses N/A N/A
PBT 96.5 42.1
Operating profit 0.0 0.0
Net profit 96.5 35.5

Shareholding Pattern

Promoters (% Holding)

72.48%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

23.96%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

1.60%

About Panacea Biotec Ltd.

Founded 1984
Managing Director Rajesh Jain
NSE Symbol PANACEABIO

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,49,251.48 1,861.90 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,78,242.24 6,678.95 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,52,951.96 4,415.00 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,16,191.66 8,028.85 6,696.50 - 6,696.50
Dr. Reddy's Laboratories Ltd. 1,06,811.05 1,281.50 1,143.90 - 1,143.90
Cipla Ltd. 1,05,391.40 1,305.50 1,165.70 - 1,165.70
Lupin Ltd. 1,02,674.68 2,274.00 1,836.80 - 1,836.80
Mankind Pharma Ltd. 1,01,937.63 2,419.05 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 1,01,003.24 1,027.55 903.00 - 903.00
Zydus Lifesciences Ltd. 96,261.37 937.95 835.50 - 835.50
no-content No Records Found

Latest News

May
7
2026
EQUITY Posted on May 7th 2026

Panacea Biotec informs about updates

Panacea Biotec has informed that it enclosed details of shares dematerialised during April 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
30
2026
EQUITY Posted on Apr 30th 2026

Panacea Biotec informs about disclosure

Pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations), Panacea Biotec has informed that the Income Tax Appellate Tribunal (ITAT) vide its Order dated April 29, 2026, allowed the appeal filed by the Company and set aside the Order dated August 14, 2025 of Commissioner of Income Tax (Appeals) (CIT(A)) arising out of Rectified Assessment Order dated October 10, 2023 passed earlier by Assessing Officer u/s 143(3) read with section 154 of the Income Tax Act, 1961 (Act). As per the aforesaid Rectified Assessment Order dated October 10, 2023, the Assessing Officer raised a demand of ₹9.16 Crore for Assessment Year 2020-21 on account of addition of ₹3.44 Crore under Section 14A of the Act read with Rule 8D of the Income Tax Rules, 1962. The aforesaid ITAT Order effectively results in deletion of the said disallowances of expenses as well as cancellation of demand of ₹9.16 Crore previously raised by Assessing Officer for the Assessment Year 2020- 21. The requisite details as required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and Industry Standards on Regulation 30 of SEBI LODR Regulations, are annexed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
1
2026
EQUITY Posted on Apr 1st 2026

Panacea Biotec informs about completion of tenure of independent director

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’), Panacea Biotec has informed that Mukul Gupta (DIN: 00254597), Independent Director of the Company has completed his second and final term of 5 consecutive years as Independent Director on March 31, 2026 and accordingly he has ceased to be an Independent director of the Company. Consequently, he has also ceased to be the Chairperson / member of the Committees of the Board of Directors of the Company. The Board of Directors and the Management of the Company express deep appreciation and gratitude to Mukul Gupta for his extensive contribution and guidance towards the business growth of the Company. The details required to be disclosed under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure - A.
The above information is a part of company’s filings submitted to BSE.
Read More
May
12
2026
EQUITY Posted on May 12th 2026

Viyash Scientific informs about board meeting

Viyash Scientific has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 19, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026; recommend dividend, if any, on the equity shares of the Company for the year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
12
2026
EQUITY Posted on May 12th 2026

Bharat Parenterals informs about earnings call

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Parenterals has informed that the Earnings Conference Call to discuss operational and financial performance of the Company for the quarter and Year ended on March 31, 2026 is scheduled to be held on Tuesday, May 19, 2026 at 03:00 pm (I.S.T.). The Invitation for the Q4FY26 Earnings Conference Call is annexed.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Panacea Biotec Ltd. ?

The current share price of Panacea Biotec Ltd. is ₹375.65 as of 2026-05-12.

The market capitalisation of Panacea Biotec Ltd. is ₹2,335.49 as of 2026-05-11.

The 1-year return of Panacea Biotec Ltd. is -4.95% as of 2026-05-12.

The P/E ratio of Panacea Biotec Ltd. is 0.00 as of 2026-05-12.

The 52-week high and low of Panacea Biotec Ltd. are ₹581.00 and ₹292.40, respectively, as of 2026-05-12.

The dividend yield of Panacea Biotec Ltd. is 0.0% as of2026-05-11.

You can buy Panacea Biotec Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Panacea Biotec Ltd. is Rajesh Jain.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore